Non-alcoholic fatty liver disease, metabolic goal achievement with incident cardiovascular disease and eGFR-based chronic kidney disease in patients with …
M Li, Z Zhao, G Qin, L Chen, J Lu, Y Huo, L Chen… - Metabolism, 2021 - Elsevier
Aims/hypothesis We aimed to evaluate the effect of NAFLD on the risk of incident
cardiovascular disease (CVD) and estimated glomerular filtration rate (eGFR)-based chronic …
cardiovascular disease (CVD) and estimated glomerular filtration rate (eGFR)-based chronic …
[PDF][PDF] 2 型糖尿病合并代谢相关脂肪性肝病患者葡萄糖目标范围内时间与肝纤维化的相关性
武攸， 连明珠， 韩冰， 吕玲， 陈琰 - 临床与病理杂志, 2021 - cdn.amegroups.cn
目的: 探讨2 型糖尿病(type 2 diabetes mellitus, T2DM) 合并代谢相关脂肪性肝病(metabolic
associated fatty liver disease, MAFLD) 患者葡萄糖目标范围内时间(time in range, TIR) …
associated fatty liver disease, MAFLD) 患者葡萄糖目标范围内时间(time in range, TIR) …
利拉鲁肽治疗非酒精性脂肪性肝病合并2 型糖尿病患者血脂, 血管内皮功能和肝纤维化指标的变化
贾晨， 张涛， 王浩， 戚凤君 - 实用肝脏病杂志, 2020 - manu43.magtech.com.cn
目的探讨应用利拉鲁肽治疗非酒精性脂肪性肝病(NAFLD) 合并2 型糖尿病(T2DM) 患者血脂,
血管内皮功能和血清肝纤维化指标的变化. 方法2014 年1 月~ 2018 年12 月我院收治的NAFLD …
血管内皮功能和血清肝纤维化指标的变化. 方法2014 年1 月~ 2018 年12 月我院收治的NAFLD …
[HTML][HTML] Nonalcoholic Fatty Liver Disease: An Important Consideration for Primary Care Providers in Hawai 'i
RJ Pattison, JP Esteban, T Sempokuya… - Hawai'i Journal of …, 2020 - ncbi.nlm.nih.gov
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease
worldwide. NAFLD is a broad term for both non-alcoholic fatty liver (NAFL), which describes …
worldwide. NAFLD is a broad term for both non-alcoholic fatty liver (NAFL), which describes …
[PDF][PDF] 1. Título del proyecto PRuDENTE: Prevención de la Diabetes con Ejercicio, Nutrición y TratamiEnto
X Biomédica, CA Aguilar, LL Muñoz, S Barquera… - interoperabilidad.incmnsz.mx
La diabetes mellitus tipo 2, altamente prevalente en población mexicana, es responsable de
complicaciones crónicas micro y macrovasculares. Esto causa la utilización de servicios se …
complicaciones crónicas micro y macrovasculares. Esto causa la utilización de servicios se …